Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Falchi

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Hematologic Malignancy Reports|August 20, 2017
Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based StrategiesLorenzo Falchi
Immunology and Allergy Clinics of North America|July 27, 2015
Eosinophilia in Hematologic DisordersLorenzo Falchi, Srdan Verstovsek
Advances in Hematology|July 5, 2012
Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's LymphomasMarco Gunnellini, Lorenzo Falchi
Immunology and Allergy Clinics of North America|July 16, 2018
Kit Mutations: New Insights and Diagnostic ValueLorenzo Falchi, Srdan Verstovsek
Annals of Hematology|August 16, 2017
The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a reviewDevendra Kc, Lorenzo Falchi, Srdan Verstovsek
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
New Therapeutic Approaches in Polycythemia VeraLorenzo Falchi, Kate J Newberry, Srdan Verstovsek
Oncoimmunology|October 14, 2024
The landscape of T-cell engagers for the treatment of follicular lymphomaAlfredo Rivas-Delgado, Ivan Landego, Lorenzo Falchi
Blood|November 2, 2022
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunitiesLorenzo Falchi, Santosha A Vardhana, Gilles A Salles
Oncoimmunology|March 6, 2024
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphomaGiulio Cassanello, Alejandro Luna de Abia, Lorenzo Falchi
British Journal of Haematology|December 17, 2016
Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?Lorenzo Falchi, Prithviraj Bose, Kate J Newberry, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Hematologic Malignancy Reports|August 20, 2017
Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based StrategiesLorenzo Falchi
Immunology and Allergy Clinics of North America|July 27, 2015
Eosinophilia in Hematologic DisordersLorenzo Falchi, Srdan Verstovsek
Advances in Hematology|July 5, 2012
Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's LymphomasMarco Gunnellini, Lorenzo Falchi
Immunology and Allergy Clinics of North America|July 16, 2018
Kit Mutations: New Insights and Diagnostic ValueLorenzo Falchi, Srdan Verstovsek
Annals of Hematology|August 16, 2017
The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a reviewDevendra Kc, Lorenzo Falchi, Srdan Verstovsek
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
New Therapeutic Approaches in Polycythemia VeraLorenzo Falchi, Kate J Newberry, Srdan Verstovsek
Oncoimmunology|October 14, 2024
The landscape of T-cell engagers for the treatment of follicular lymphomaAlfredo Rivas-Delgado, Ivan Landego, Lorenzo Falchi
Blood|November 2, 2022
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunitiesLorenzo Falchi, Santosha A Vardhana, Gilles A Salles
Oncoimmunology|March 6, 2024
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphomaGiulio Cassanello, Alejandro Luna de Abia, Lorenzo Falchi
British Journal of Haematology|December 17, 2016
Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?Lorenzo Falchi, Prithviraj Bose, Kate J Newberry, et al.
Pageof 8